Biotech Turnaround Fund (BTF) B.V. is a cross-over, turnaround venture capital operating company, focusing on building a portfolio of six late-stage biotechnology companies. Companies with several drug development candidates in phase II clinical trials.
| Company | Date | Round | Size | Participants |
| Metabolex | 4/07 | Series D | $32M | 16 |
